OncoMatch/Clinical Trials/Neuroendocrine Tumor (NET)
Neuroendocrine Tumor (NET) Clinical Trials
OncoMatch filters Neuroendocrine Tumor (NET) trials by the molecular markers that determine eligibility — SSTR2, MEN1, DAXX, CD274, and more. Enter your biomarker results to see only the trials you may qualify for.
Compare eligibility criteriaBiomarkers tested in Neuroendocrine Tumor (NET) trials
These are the molecular markers most commonly required or evaluated in Neuroendocrine Tumor (NET) eligibility criteria. OncoMatch extracts them from each trial's protocol and matches them against your test results.
Top recruiting Neuroendocrine Tumor (NET) trials
Ranked by phase and number of US sites. See all trials matched to your profile →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Exelixis
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
RayzeBio, Inc.
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Novartis Pharmaceuticals
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Crinetics Pharmaceuticals Inc.
Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs)
Intergroupe Francophone de Cancerologie Thoracique
Application of Al18F-octreotide PET/CT in Neuroendocrine Tumor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
How OncoMatch finds Neuroendocrine Tumor (NET) trials for you
AI reads the protocol
Every Neuroendocrine Tumor (NET) trial on ClinicalTrials.gov has eligibility criteria written for regulators. OncoMatch uses large language models to extract the structured requirements — biomarkers, stage, prior therapy, and more — from that text.
You enter your results
Select Neuroendocrine Tumor (NET) and mark your biomarker results — SSTR2, MEN1, DAXX — as positive, negative, or not tested. Your data never leaves your device.
See only relevant trials
Results filter instantly. Each trial shows exactly which criteria you meet, which you don't, and which need more information. Bring the list to your oncologist.